Cobicistat : A case of mislabelled drug-drug interaction risk?
ContributorsBurger, David M ; Calmy, Alexandra ; Marzolini, Catia
Published inBritish journal of clinical pharmacology, vol. 86, no. 5, p. 834-836
Publication date2020-05
First online date2020-03-06
Keywords
- HIV/AIDS
- Cytochrome P450
- Drug interactions
- Anti-HIV Agents / pharmacology
- Cobicistat / pharmacology
- Darunavir
- Drug Interactions
- Drug Labeling
- HIV Infections / drug therapy
- Humans
- Pharmaceutical Preparations
Affiliation entities
Research groups
Citation (ISO format)
BURGER, David M, CALMY, Alexandra, MARZOLINI, Catia. Cobicistat : A case of mislabelled drug-drug interaction risk? In: British journal of clinical pharmacology, 2020, vol. 86, n° 5, p. 834–836. doi: 10.1111/bcp.14262
Main files (1)
Article (Published version)
Identifiers
- PID : unige:173261
- DOI : 10.1111/bcp.14262
- PMID : 32144787
- PMCID : PMC7163374
ISSN of the journal0306-5251